Physician profile
Isaac Demke
NPI 1487278750
$245.69
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.86 · 2021: $42.00 · 2022: $133 · 2023: $57.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $45.91 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $42.33 | 2022-2023 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $30.31 | 2020-2022 | |
| Amgen INC. | $30.06 | 2021-2022 | |
| Mylan Specialty L.P. | $16.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.22 | 2023 | |
| Biogen, INC. | $14.76 | 2021 | |
| Merck Sharp & Dohme LLC | $13.61 | 2022 | |
| Seqirus USA INC | $12.85 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.27 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Demke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.